TGFB1 and gastric cancer: Since depleting neutrophils or inhibiting NETs are not clinically feasible due to risk of infection or sepsis, our findings that TGF-β signaling may be targeted therapeutically to reduce metastasis in the context of metastasis-supporting NETs-GC clusters provides the prospect to mitigate the adverse oncologic consequences in locally advanced GC patients experiencing postoperative AIC.